尊龙凯时
About us
尊龙凯时:Our Values
尊龙凯时:Development Milestone
Products
尊龙凯时:Product List for API
尊龙凯时:Recommended API
尊龙凯时:Product list for Chemicals and Intermediates
Product list for Chemicals and Intermediates
News
尊龙凯时:Contract Manufacturing
尊龙凯时:API and Pharmaceutical Intermediates
尊龙凯时:OTC and Generics
尊龙凯时:Investor Relation
PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
尊龙凯时:Contact Us
About us
News
尊龙凯时:Investor Relation
Products
尊龙凯时:Contract Manufacturing
尊龙凯时:Contact Us
Investor Relation
Investor Relation
尊龙凯时:PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
Poll Results of The Extraordinary General Meeting
2024-10-25
Announcement Notice of Board Meeting
2024-10-14
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2024
2024-10-03
Reply Slip for the First Extraordinary General Meeting for the Year 2024
2024-10-03
Proxy Form for the First Extraordinary General Meeting for the Year 2024
2024-10-03
Notice of Extraordinary General Meeting
2024-10-03
Proposed Amendments to the Articles of Association, the Rules and Procedures for General Meetings,Board Meetings and Supervisors Meetings and Notice of Extraordinary General Meeting
2024-10-03
Proposed Amendments to the Articles of Association and Relevant Rules and Procedures
2024-09-30
Overseas Regulatory Announcement-Announcement on Having Obtained the Notification of Approval of Supplementary Drug Application and Other Relevant Information
2024-09-13
Overseas regulatory announcement-Announcement on Obtaining Approval Notice for Supplementary Drug Application and Other Relevant Information
2024-09-03
<
...
2
3
4
5
6
7
8
...
>